Brinton Bio
AI & Life Sciences Strategy for Investors and Innovators.
We help biotech companies and portfolio assets scale efficiently, reduce risk, and accelerate value creation.
Built for operators. Designed for investors.
We work with biotech and pharma executives navigating complex operational change—and with PE and VC investors who need independent expertise on portfolio company performance, due diligence, and value creation.
AI That Actually Works
Most AI initiatives fail because they optimize one dimension (People, Tools, Workflow) while ignoring the others. Real value creation requires equilibrium.
The recent LLM revolution is still fresh, but we are steeped in its strategic design, build, and testing. We have seen the mistakes - repeatedly. We catalogued the lessons learned.
When these three forces reach equilibrium, AI stops being a science project and starts driving measurable results. We design for all three from day one.
